Skip to main content

Bipolar Disorders

Featured Article
The FDA has issued a Class II recall for a prescription anticonvulsant used to treat people with seizures, nerve pain, or bipolar disorder.
Alkermes plc is expanding its New Drug Application (NDA) for the investigational drug ALKS 3831—a combination of the antipsychotic olanzapine and the novel molecular entity samidorphan—to include the…

Insights

Treatment of geriatric bipolar disorder is complex and generally managed by a psychiatrist, but geriatricians and the entire SNF treatment team play important roles in managing these patients. 
There is now a greater understanding of the neurobiologic basis of pediatric bipolar spectrum disorder.
Back to Top